We’re starting a position in a chip designer poised to roar in the era of AI agents
We’re initiating a position in Arm Holdings , buying 225 shares at roughly $169. Following Monday’s trade, Jim…
The private equity crunch is not a prelude to the next crisis
We are fixated on two problems: the price of oil and the frailty of our banking system. We…
‘It’s the beginning’ — Cramer warns the weak payroll report shows AI-related job losses are here
CNBC’s Jim Cramer on Friday expressed concern about the surprisingly weak February jobs report . The line that…
We’re dipping into our large cash pile to buy more of this health-care stock
We are buying 90 shares of Cardinal Health at roughly $217. Following the trade, Jim Cramer’s Charitable Trust…
We’re increasing our price target on Bristol Myers after earnings and guidance top forecasts
Bristol Myers Squibb on Thursday delivered strong fourth quarter results — and better yet, issued a 2026 forecast…
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
“I’m Backing off on It”
Bristol-Myers Squibb Company (NYSE:BMY) is one of the stocks Jim Cramer offered insights on. Answering a caller’s query…
Jim Cramer’s top 10 things to watch in the stock market Thursday
My top 10 things to watch Thursday, Oct. 23 1. Wall Street was headed for a lower open…
Here are the 3 big things we’re watching in the stock market in this week
Last week started with the big banks delivering strong earnings and ended with regional lenders writing off bad…
3 big things we’re watching in the stock market in the week ahead
The federal government closed up shop last week. You might not have known that if the stock market’s…